VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.98 Cr | ₹2.49 Cr | ₹2.44 Cr | ₹3.14 Cr | ₹2.82 Cr |
What is the latest Contingent Liabilities ratio of VIMTA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.98 Cr |
Mar2023 | ₹2.49 Cr |
Mar2022 | ₹2.44 Cr |
Mar2021 | ₹3.14 Cr |
Mar2020 | ₹2.82 Cr |
How is Contingent Liabilities of VIMTA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.98 Cr | 100.12 | |
Mar2023 | ₹2.49 Cr | 1.97 | |
Mar2022 | ₹2.44 Cr | -22.22 | |
Mar2021 | ₹3.14 Cr | 11.16 | |
Mar2020 | ₹2.82 Cr | - |
Compare Contingent Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,392.3 Cr | 4.6% | 30.5% | 127.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,044.0 Cr | -0.2% | -1% | 9.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,537.0 Cr | -2.1% | 1.5% | 61.3% | Stock Analytics | |
CIPLA | ₹118,889.0 Cr | -0% | 2% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,075.0 Cr | -1.4% | -6.1% | -4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,832.5 Cr | -5.2% | -4.7% | 8.9% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 4.6% |
30.5% |
127.2% |
SENSEX | -2.5% |
-0.8% |
7.1% |
You may also like the below Video Courses